Impact of Adverse Gestational Milieu on Maternal Cardiovascular Health

Bashar Alkhatib, Shadi Salimi, Mary Jabari, Vasantha Padmanabhan, Arpita Kalla Vyas

Research output: Contribution to journalReview articlepeer-review

3 Scopus citations


Cardiovascular disease affects 1% to 4% of the nearly 4 million pregnancies in the United States each year and is the primary cause of pregnancy-related mortality. Adverse pregnancy outcomes are associated with cardiovascular complications during pregnancy persisting into the postpartum period. Recently, investigations have identified an altered sex hormone milieu, such as in the case of hyperandrogenism, as a causative factor in the development of gestational cardiovascular dysfunction. The mechanisms involved in the development of cardiovascular disease in postpartum women are largely unknown. Animal studies have attempted to recapitulate adverse pregnancy outcomes to investigate causal relationships and molecular underpinnings of adverse gestational cardiac events and progression to the development of cardiovascular disease postpartum. This review will focus on summarizing clinical and animal studies detailing the impact of adverse pregnancy outcomes, including preeclampsia, gestational diabetes mellitus, and maternal obesity, on gestational cardiometabolic dysfunction and postpartum cardiovascular disease. Specifically, we will highlight the adverse impact of gestational hyperandrogenism and its potential to serve as a biomarker for maternal gestational and postpartum cardiovascular dysfunctions.

Original languageEnglish
Issue number6
StatePublished - Apr 17 2023


  • cardiovascular disease
  • gestational diabetes mellitus
  • gestational hyperandrogenism
  • maternal health
  • polycystic ovarian syndrome
  • preeclampsia
  • pregnancy


Dive into the research topics of 'Impact of Adverse Gestational Milieu on Maternal Cardiovascular Health'. Together they form a unique fingerprint.

Cite this